Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Digital Therapeutics Landscape in Europe

    September 3, 2020 |  

    OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK

    Digital Therapeutics Landscape in Europe: The Case of Germany and the UK

    The COVID-19 virus crisis has opened immense windows of opportunity in healthcare around the globe. One of the greatest opportunities is in digital health, and in particular, digital therapeutics (DTx). The need for continued medical care combined with social distancing has led to a spike in use of digital health tools worldwide.1 As the interest in and use of digital health has grown during this period, we anticipate that investments in digital health tools will continue to accelerate after the COVID-19 pandemic. When the COVID-19 outbreak started, millions of Chinese people turned to online doctors and online health tools1 to find the needed support for their health. While these developments could create new risks for privacy and data protection, they also represent an unprecedented opportunity to integrate industry 4.0 in healthcare for the benefit of patients.

    HIGHLIGHTS INCLUDE:
    • Opportunities and threats of digital therapeutics after COVID-19
    • Digital therapeutics landscape in the European Union
    • Review and comparison of the German and UK therapeutics landscape
    • Develop game-changing insights and competitive advantage on both a global and local scalepi

    Pink divider

    Download the white paper and learn how it’s happening now!

    Download the Paper- PMLiVE

    1. https://www.cnbc.com/2020/03/26/investments-in-digital-health-care-could-accelerate-after-coronavirus-credit-suisse-says.html

    This content was provided by OPEN Health

    Company Details

    OPEN Health

    OPEN Health

    Email
    Website

     Latest Content from  OPEN Health 

    Patient journey mapping: exploring the clinical and the emotional journey

    By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...

    OPEN Health announces the integration of Pharmerit International into the group

    OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.

    OPEN Health mobilised to support outcomes with gene and other advanced therapies

    Harnessing the power of collaborations to bring real insights and improve outcomes

    Spotlight interview: 15 minutes on PR in pharma

    Vicky Bramham, Managing Director, OPEN Health takes 15 minutes to answer some key questions on PR discipline.

    OPEN Health PBC recognised as No. 1 independent creative agency

    We’re No.1! PMLive have named OPEN Health Patient & Brand Communications as the no.1 independent creative healthcare agency. The aim of the PMLive Top 10 lists is to highlight those...

    Spotlight interview: 15 minutes on medical and scientific writing

    Rob Pilbrow, Global Managing Director, Medical Writing, OPEN Health takes 15 minutes to answer some key questions on scientific writing

    Spotlight interview: 15 minutes on healthcare advertising

    Marie Little, Managing Director, OPEN Health Patient & Brand Communications takes 15 minutes to answer some key questions on healthcare advertising

    Alexander Devine Website has gone live!

    As part of the OPEN Health CSR programme one of the charities we support is Alexander Devine. They are a local Children's Hospice based in Maidenhead who provide a truly...

    Spotlight interview: 15 minutes on patient-centricity in pharma

    Sumira Riaz, Health Psychologist at OPEN Health Patient & Brand Communications, takes 15 minutes to answer some key questions on patient-centricity in pharma.

    Spotlight interview: 15 minutes on patient engagement in pharma

    Richard Jones, Managing Director Patient Engagement, OPEN Health Patient and Brand Communications, takes 15 minutes to answer some key questions on patient engagement in pharma